motesanib (AMG 706)

News alerts, weekly reports and conference planners

Company:

Amgen, Takeda

Drug class:

Multi-tyrosine kinase inhibitor

Related drugs:

‹

›

RET M918T	Thyroid Gland Medullary Carcinoma	RET M918T	Thyroid Gland Medullary Carcinoma	AMG 706 Resistant: D – Preclinical AMG 706 Resistant : D	AMG 706 Resistant: D – Preclinical AMG 706 Resistant : D
RET C634W	Thyroid Gland Medullary Carcinoma	RET C634W	Thyroid Gland Medullary Carcinoma	AMG 706 Resistant: D – Preclinical AMG 706 Resistant : D	AMG 706 Resistant: D – Preclinical AMG 706 Resistant : D

Associations
(2)